Deutsche Börse and RegTek.Solutions Partner on Pre-Validation Service

New platform aims to address data quality challenges and transparency of transaction reporting regulated by Mifir.

reports-stack

Deutsche Börse Group is teaming up with RegTek.Solutions to create a regulatory reporting pre-validation service. The more than 2,300 entities that use Deutsche Börse’s Approved Reporting Mechanism (ARM) service can access the platform via the Frankfurt-based transaction services vendor’s Regulatory Reporting Hub. 

Brian Lynch, RegTek.Solutions

“Deutsche Börse is a central utility player, whereas RegTek.Solutions operates more on a federated basis putting tools

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

‘Feature, not a bug’: Bloomberg makes the case for Figi

Bloomberg created the Figi identifier, but ceded all its rights to the Object Management Group 10 years ago. Here, Bloomberg’s Richard Robinson and Steve Meizanis write to dispel what they believe to be misconceptions about Figi and the FDTA.

Where have all the exchange platform providers gone?

The IMD Wrap: Running an exchange is a profitable business. The margins on market data sales alone can be staggering. And since every exchange needs a reliable and efficient exchange technology stack, Max asks why more vendors aren’t diving into this space.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here